GSK Files Annual Report for Fiscal Year 2017
GSK plc has filed its annual report, Form 20-F, with the U.S. Securities and Exchange Commission (SEC) for the fiscal year ending December 31, 2017.
Pharmaceutical giant GSK plc (GlaxoSmithKline) has officially submitted its annual report, Form 20-F, to the U.S. Securities and Exchange Commission (SEC) on March 16, 2018. The filing covers the fiscal year that concluded on December 31, 2017.
The report serves as an annual statement as required by the U.S. Securities Exchange Act. GSK plc is incorporated in England, with its principal executive offices located at 980 Great West Road, Brentford, Middlesex.
GSK's submission details the company's operations, financial standing, and future prospects. The financial statements within the report are prepared in accordance with International Financial Reporting Standards (IFRS). The report also lists the classes of securities registered by the company on the New York Stock Exchange and the London Stock Exchange.
The company confirmed in its filing that it has met all reporting requirements for the preceding 12 months and has been subject to such requirements for the past 90 days. GSK plc is defined as a "large accelerated filer" under SEC rules.
The document also outlines information concerning its directors, senior management, employees, major shareholders, and other disclosures mandated by securities regulations.